Clinical Trials for AraC

1 Open Trial

Trial TypeProtocol No. &
Open Date
Summary
TreatmentECOGHEMS1203
07/26/2013
A Randomized Phase III Study of Standard Cytarabine plus Daunorubicin (7+3) Therapy or Idarubicin with High Dose Cytarabine (IA) versus IA with Vorinostat (IA+V) in Younger Patients with Previously Untreated Acute Myeloid Leukemia (AML)

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.